anthranilamide has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Cheng, C; Liu, X; Tang, P; Wu, X; Xie, R; Yao, Y; Yuan, Q; Yun, F | 1 |
| Bondavalli, F; Botta, M; Schenone, S | 1 |
1 review(s) available for anthranilamide and Neoplasms
| Article | Year |
|---|---|
Antiangiogenic agents: an update on small molecule VEGFR inhibitors.
Topics: Angiogenesis Inhibitors; Animals; Chemistry, Pharmaceutical; Drug Design; Humans; Indoles; Inhibitory Concentration 50; Models, Chemical; Neoplasms; Neovascularization, Pathologic; ortho-Aminobenzoates; Phthalimides; Receptors, Vascular Endothelial Growth Factor; RNA, Catalytic; Signal Transduction; Triazines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
1 other study(ies) available for anthranilamide and Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
Topics: A549 Cells; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Docking Simulation; Neoplasms; ortho-Aminobenzoates | 2017 |